title: n-3 Fatty acids and cardiovascular disease risk factors among the Inuit of Nunavik.
abstract: BACKGROUND
  Inuit traditionally consume large amounts of marine foods rich in n-3 fatty acids. Evidence exists that n-3 fatty acids have beneficial effects on key risk factors for cardiovascular disease.
  
  
  OBJECTIVE
  Our goal was to verify the relation between plasma phospholipid concentrations of the n-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) and various cardiovascular disease risk factors among the Inuit of Nunavik, Canada.
  
  
  METHODS
  The study population consisted of 426 Inuit aged 18-74 y who participated in a 1992 health survey. Data were obtained through home interviews and clinical visits. Plasma samples were analyzed for phospholipid fatty acid composition.
  
  
  RESULTS
  Expressed as the percentage of total fatty acids, geometric mean concentrations of EPA, DHA, and their combination in plasma phospholipids were 1.99%, 4.52%, and 6.83%, respectively. n-3 Fatty acids were positively associated with HDL-cholesterol concentrations and inversely associated with triacylglycerol concentrations and the ratio of total to HDL cholesterol. In contrast, concentrations of total cholesterol, LDL cholesterol, and plasma glucose increased as n-3 fatty acid concentrations increased. There were no significant associations between n-3 fatty acids and diastolic and systolic blood pressure and plasma insulin.
  
  
  CONCLUSIONS
  Consumption of marine products, the main source of EPA and DHA, appears to beneficially affect some cardiovascular disease risk factors. The traditional Inuit diet, which is rich in n-3 fatty acids, is probably responsible for the low mortality rate from ischemic heart disease in this population.
authors.affiliation: Public Health Research Unit, CHUL Research Center, Centre Hospitalier Universitaire de Quebec, Ste-Foy, Canada. eric.dewailly@crchul.ulaval.ca
authors.forename: E
authors.initials: E
authors.lastname: Dewailly
authors.forename: C
authors.initials: C
authors.lastname: Blanchet
authors.forename: S
authors.initials: S
authors.lastname: Lemieux
authors.forename: L
authors.initials: L
authors.lastname: Sauvé
authors.forename: S
authors.initials: S
authors.lastname: Gingras
authors.forename: P
authors.initials: P
authors.lastname: Ayotte
authors.forename: B J
authors.initials: BJ
authors.lastname: Holub
mesh_terms: D000328:Adult; D000368:Aged; D000886:Anthropometry; D001786:Blood Glucose; D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control*; D002784:Cholesterol / Q000097:blood; D004032:Diet; D015525:Fatty Acids, Omega-3 / Q000008:administration & dosage* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007328:Insulin / Q000097:blood; D004930:Inuit; D008019:Life Style; D008297:Male; D008875:Middle Aged; D010743:Phospholipids / Q000097:blood*; D011792:Quebec; D012307:Risk Factors
chemical_list: D001786:Blood Glucose; D015525:Fatty Acids, Omega-3; D007328:Insulin; D010743:Phospholipids; D002784:Cholesterol